FDA Takes Long-Awaited Action On Labeling Plant-Based Milk Alternatives

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Following several years of lead-up, including public engagement, the review of more than 13,000 comments, and conducting focus group studies, on February 22, 2023, the U.S. Food and Drug Administration ("FDA") issued a draft guidance on the labeling of plant-based milk alternatives ("PBMA").
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Following several years of lead-up, including public engagement, the review of more than 13,000 comments, and conducting focus group studies, on February 22, 2023, the U.S. Food and Drug Administration ("FDA") issued a draft guidance on the labeling of plant-based milk alternatives ("PBMA").

Plant-based milk labeling has received considerable scrutiny as the products have gained popularity and has been the subject of lawsuits, proposed federal legislation, U.S. Department of Agriculture ("USDA") investigations, and state bills and resolution as states try to fill a federal void. FDA's draft guidance on PBMA labeling now enters the fray.

In the draft, FDA takes the position that PBMA are non-standardized foods because no definition or standard of identity has been prescribed for them by regulation. Accordingly, the FDA maintains PBMA must be labeled with their common or usual names, or in the absence thereof, a statement of identity that accurately describes them. The names of some PBMA appear to be established by common usage (e.g., "soy milk," "almond milk"). While "plant-based" or "plant" may be used to describe PBMA, FDA, in the draft guidance, does not recommend using only these terms, since "plant-based milk" is not the common or usual name of PBMA.

Per FDA, since PBMA are not milk, they may not be offered for sale as "milk," although they may use the word "milk" in labeling, as long as it is qualified by the plant source. Notably, however, with such usage of the word "milk," FDA recommends that PBMA products that have a nutrient composition different than milk bear an additional nutrient statement on the product label. This statement-which is voluntary-should, according to the FDA, describe how the PBMA product compares with milk, based on the USDA's Food and Nutrition Service ("FNS") fluid milk substitutes nutrient criteria.

FDA notes that not all PBMA meet the definition of an imitation food, but to the extent they do, the agency intends to exercise enforcement discretion with respect to inclusion of the word "imitation" in the food name.

The draft guidance will likely continue the controversy and interested parties should comment by April 24, 2023.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More